Lab
Sema4 Opco, INC
Sema4 Opco, INC was paid $10.85M by Medicaid between Jan 2018 and Dec 2022, across 80 billing codes. Its largest line is 81420, Fetal chromosomal aneuploidy genomic sequence analysis panel — 26% of everything it billed.
33Billing provider infoSEMA4 OPCO, INC
BRANFORD, CT 06405
BRANFORD, CT 06405
33aNPI1518415991assigned 09/14/2016
33bProvider typeClinical Medical Laboratory
28Total paid$10.85M
24GClaims378,156
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Connecticut
Rank by total paid#1 of 27
Median peer was paid$561K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,082 | $985K | |
| 2019 | 44,079 | $1.07M | |
| 2020 | 56,313 | $1.22M | |
| 2021 | 134,189 | $2.22M | |
| 2022 | 112,493 | $5.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 26% | 9,411 | 9,208 | $2.77M |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 20% | 11,676 | 11,431 | $2.12M |
| 81408 | 10% | 10,773 | 10,550 | $1.10M | |
| 81407 | 4.1% | 9,704 | 9,514 | $450K | |
| 81329 | 3.2% | 9,546 | 9,393 | $349K | |
| 81406 | 3.2% | 11,606 | 11,311 | $344K | |
| 81422 | 3.0% | 2,896 | 2,854 | $326K | |
| 81162 | 2.2% | 903 | 883 | $236K | |
| 81404 | 2.0% | 11,350 | 11,101 | $220K | |
| 81405 | 2.0% | 11,097 | 10,823 | $212K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 29,918 | 13,740 | $188K |
| 81251 | 1.6% | 9,246 | 9,066 | $175K |
68 more codes
| 83080 | 1.5% | 9,754 | $167K | |
| 81401 | 1.5% | 11,005 | $166K | |
| 81243 | 1.3% | 10,103 | $139K | |
| 82657 | 1.3% | 8,765 | $137K | |
| 81205 | 1.1% | 8,700 | $115K | |
| 81255 | <1% | 9,112 | $84K | |
| 81402 | <1% | 10,176 | $82K | |
| 81161 | <1% | 9,453 | $80K | |
| 81250 | <1% | 8,711 | $79K | |
| 88230 | <1% | 1,207 | $79K | |
| 80500 | <1% | 8,951 | $76K | |
| 81400 | <1% | 9,206 | $75K | |
| 81321 | <1% | 642 | $74K | |
| 81330 | <1% | 8,925 | $69K | |
| 81200 | <1% | 9,095 | $68K | |
| 81257 | <1% | 10,200 | $66K | |
| 88262 | <1% | 889 | $63K | |
| 81242 | <1% | 9,049 | $58K | |
| 81260 | <1% | 8,779 | $47K | |
| 81290 | <1% | 8,700 | $47K | |
| 81209 | <1% | 8,710 | $47K | |
| 88235 | <1% | 432 | $46K | |
| 81403 | <1% | 1,952 | $36K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 756 | $31K |
| 81311 | <1% | 278 | $27K | |
| 88291 | <1% | 1,749 | $25K | |
| 84155 | <1% | 10,932 | $25K | |
| 81252 | <1% | 9,080 | $24K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 27,807 | $24K |
| 84704 | <1% | 2,404 | $24K | |
| 81228 | <1% | 710 | $22K | |
| 82542 | <1% | 1,277 | $22K | |
| 82105 | <1% | 3,184 | $21K | |
| 88289 | <1% | 965 | $21K | |
| 81265 | <1% | 299 | $20K | |
| 81291 | <1% | 8,069 | $19K | |
| 82136 | <1% | 1,695 | $17K | |
| 84163 | <1% | 1,819 | $17K | |
| 81201 | <1% | 152 | $14K | |
| 81292 | <1% | 205 | $12K | |
| 88271 | <1% | 308 | $11K | |
| 81432 | <1% | 190 | $10K | |
| 82677 | <1% | 556 | $10K | |
| 81298 | <1% | 229 | $7K | |
| 82139 | <1% | 765 | $5K | |
| 88274 | <1% | 305 | $5K | |
| 86906 | <1% | 801 | $4K | |
| 82017 | <1% | 341 | $4K | |
| 81317 | <1% | 194 | $4K | |
| 81300 | <1% | 215 | $3K | |
| 83520 | <1% | 295 | $3K | |
| 81433 | <1% | 187 | $3K | |
| 81295 | <1% | 192 | $3K | |
| 81323 | <1% | 255 | $2K | |
| 81294 | <1% | 188 | $2K | |
| 81297 | <1% | 188 | $2K | |
| 81307 | <1% | 123 | $2K | |
| 81319 | <1% | 188 | $2K | |
| 82570 | <1% | 344 | $1K | |
| 88280 | <1% | 41 | $885.12 | |
| 88285 | <1% | 54 | $816.10 | |
| 81210 | <1% | 26 | $701.60 | |
| 86336 | <1% | 62 | $606.86 | |
| 81223 | <1% | 15 | $349.30 | |
| 82106 | <1% | 26 | $336.85 | |
| 81235 | <1% | 15 | $333.67 | |
| 83921 | <1% | 18 | $287.40 | |
| 81206 | <1% | 12 | $200.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWATIMAR, DANIELLE (PAYOR ANALYST)